Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition
- PMID: 8547185
- DOI: 10.1016/0960-0760(95)00209-x
Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition
Abstract
Following transfection of types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) cDNAs into transformed embryonal kidney (293) cells, we have characterized the selective directional and inhibitory characteristics of these activities. While homogenates of transfected cells could catalyze interconversion of the substrate and product, in agreement with the general belief on the activity of these enzymes, the same activities measured in intact cells, in order to better reflect the physiological conditions, showed an unidirectional reaction. Types 1 and 3 17 beta-HSD catalyzed the reduction of estrone to estradiol and 4-androstenedione to testosterone, respectively, while type 2 17 beta-HSD catalyzed the oxidative transformation of both testosterone and 17 beta-estradiol to 4-androstenedione and estrone, respectively. In addition, types 1, 2 and 3 17 beta-HSD activities showed different pH optima. While types 1 and 3 showed pH optimum values centered at around 5 and 6, respectively, type 2 17 beta-HSD activity, which preferentially, catalyzes the oxidation reaction, has higher activity at an alkaline pH (8-10). Differences in the optimum incubation temperatures were also observed: type 1 17 beta-HSD shows a relatively high temperature tolerance (55 degrees C). In contrast, type 2 and 3 functioned best at 37 degrees C. Types 1, 2 and 3 17 beta-HSD activities could be also differentiated by their sensitivity toward various specific inhibitors: type 1 was potently inhibited by an estradiol derivative containing a bromo/or iodopropyl group at position 16 alpha. On the other hand a derivative of estrone containing a spiro-gamma-lactone at position 17 showed a potent inhibitory effect on type 2 17 beta-HSD, whereas type 3 was strongly inhibited by 1,4-androstadiene-1,6,17- trione.
Similar articles
-
Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.J Steroid Biochem Mol Biol. 2003 Jul;86(1):79-92. doi: 10.1016/s0960-0760(03)00251-6. J Steroid Biochem Mol Biol. 2003. PMID: 12943747
-
The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.Steroids. 1997 Jan;62(1):148-58. doi: 10.1016/s0039-128x(96)00174-2. Steroids. 1997. PMID: 9029730
-
Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.Mol Cell Endocrinol. 2001 Jan 22;171(1-2):119-28. doi: 10.1016/s0303-7207(00)00427-5. Mol Cell Endocrinol. 2001. PMID: 11165020
-
Kinetic analysis of enzymic activities: prediction of multiple forms of 17 beta-hydroxysteroid dehydrogenase.J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):515-24. doi: 10.1016/0960-0760(95)00200-6. J Steroid Biochem Mol Biol. 1995. PMID: 8547176 Review.
-
Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases.Steroids. 1997 Jan;62(1):143-7. doi: 10.1016/s0039-128x(96)00173-0. Steroids. 1997. PMID: 9029729 Review.
Cited by
-
Expression and localization of estrogenic type 12 17beta-hydroxysteroid dehydrogenase in the cynomolgus monkey.BMC Biochem. 2007 Feb 5;8:2. doi: 10.1186/1471-2091-8-2. BMC Biochem. 2007. PMID: 17280614 Free PMC article.
-
Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3.Animals (Basel). 2021 Sep 30;11(10):2876. doi: 10.3390/ani11102876. Animals (Basel). 2021. PMID: 34679897 Free PMC article.
-
In silico discovery of gene-coding variants in murine quantitative trait loci using strain-specific genome sequence databases.Genome Biol. 2002;3(12):RESEARCH0078. doi: 10.1186/gb-2002-3-12-research0078. Epub 2002 Nov 27. Genome Biol. 2002. PMID: 12537567 Free PMC article.
-
Expression, purification, and characterization of a human recombinant 17beta-hydroxysteroid dehydrogenase type 1 in Escherichia coli.Mol Biotechnol. 2010 Feb;44(2):133-9. doi: 10.1007/s12033-009-9221-5. Mol Biotechnol. 2010. PMID: 19915984
-
Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene.Mol Endocrinol. 2008 Mar;22(3):665-75. doi: 10.1210/me.2007-0257. Epub 2007 Nov 29. Mol Endocrinol. 2008. PMID: 18048640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases